JF
Johanna Friedl-Naderer
DELAYED 1 MONTH
Chief Commercial Officer
Dyne Therapeutics, Inc.
Filings
2
Companies
1
Latest
May 13, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
60
DYNCLUSTER 5
Dyne Therapeutics, Inc.
Johanna Friedl-Naderer
Chief Commercial Officer
Sale
$4.2K
228 sh
May 14 8:05 PM
May 13, 2026
56
DYNCLUSTER 3
Dyne Therapeutics, Inc.
Johanna Friedl-Naderer
Chief Commercial Officer
Sale
$2.2K
148 sh
Mar 6 9:10 PM
Mar 5, 2026